谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Trial Protocol 1 from A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy

Sarah A. Weiss,Mario Sznol, Montaser Shaheen,Miguel-Ángel Berciano-Guerrero,Eva Muñoz Couselo,Delvys Rodríguez-Abreu,Valentina Boni,Lynn M. Schuchter,Maria Gonzalez-Cao,Ana Arance, Wei,Apar Kishor Ganti,Ralph J. Hauke,Alfonso Berrocal, Nicholas O. Iannotti,Frank J. Hsu,Harriet M. Kluger

crossref（2024）

引用 0|浏览7
暂无评分
摘要
Representativeness of Study Participants
更多
查看译文
关键词
Combination Therapies
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要